VIVOVERSE Trademark

Trademark Overview


On Monday, May 16, 2022, a trademark application was filed for VIVOVERSE with the United States Patent and Trademark Office. The USPTO has given the VIVOVERSE trademark a serial number of 97411982. The federal status of this trademark filing is REGISTERED as of Tuesday, October 22, 2024. This trademark is owned by Newormics LLC. The VIVOVERSE trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Instruments for evaluating and reporting the scientific makeup of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs; instruments for identifying the cellular or molecular makeup of body fluid samples, blood samples, DNA and RNA samples, body tissue samples and C. elegans; instruments for performing chemical and molecular screening analyses; toxicology screening instruments, namely, laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; instruments for determining the scientific makeup of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs

DNA screening services of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs for scientific research purposes wherein body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs are evaluated for purposes of identifying their precise scientific makeup; chemical and substance screening services, namely, toxicology screening services and drug screening for scientific research purposes for body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs; DNA screening services for scientific research purposes for identifying the cellular or molecular composition of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs; toxicology screening services
vivoverse

General Information


Serial Number97411982
Word MarkVIVOVERSE
Filing DateMonday, May 16, 2022
Status700 - REGISTERED
Status DateTuesday, October 22, 2024
Registration Number7545364
Registration DateTuesday, October 22, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesInstruments for evaluating and reporting the scientific makeup of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs; instruments for identifying the cellular or molecular makeup of body fluid samples, blood samples, DNA and RNA samples, body tissue samples and C. elegans; instruments for performing chemical and molecular screening analyses; toxicology screening instruments, namely, laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; instruments for determining the scientific makeup of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs
Translation of Words in MarkThe English translation of "VIVO" in the mark is "ALIVE".
Goods and ServicesDNA screening services of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs for scientific research purposes wherein body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs are evaluated for purposes of identifying their precise scientific makeup; chemical and substance screening services, namely, toxicology screening services and drug screening for scientific research purposes for body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs; DNA screening services for scientific research purposes for identifying the cellular or molecular composition of body fluid samples, blood samples, DNA and RNA samples, body tissue samples, C. elegans and prescription drugs; toxicology screening services

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code009
First Use Anywhere DateSunday, December 11, 2022
First Use In Commerce DateSunday, December 11, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code042
First Use Anywhere DateSunday, December 11, 2022
First Use In Commerce DateSunday, December 11, 2022

Trademark Owner History


Party NameNewormics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78703

Party NameNewormics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78703

Party NameNewormics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78703

Trademark Events


Event DateEvent Description
Thursday, May 19, 2022NEW APPLICATION ENTERED
Monday, May 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023ASSIGNED TO EXAMINER
Thursday, March 9, 2023NON-FINAL ACTION WRITTEN
Thursday, March 9, 2023NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 12, 2023FINAL REFUSAL WRITTEN
Monday, June 12, 2023FINAL REFUSAL E-MAILED
Monday, June 12, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 12, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, September 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, September 14, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, September 14, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 20, 2024USE AMENDMENT FILED
Thursday, June 20, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, August 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 17, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 17, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 22, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED